Skip to content

A randomized , placebo controlled trial The effect of non-surgical periodontal therapy with adjunctive topical doxycycline gel on HbA1c in patients with type 2 diabetes mellitus (DM).

The effect of non-surgical periodontal therapy with adjunctive topical doxycycline gel on HbA1c in patients with type 2 diabetes mellitus(DM).

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015010517587N8
Enrollment
24
Registered
2015-02-10
Start date
2015-01-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontitis. Periodontitis

Interventions

Intervention 1: "Intervention group": Doxycycline(3 percent ) gel was manufactured by shahin khapour harmaceutical Laboratory,Tehran- Iran . Intervention 2: "Control group":Placebo gel of was prepared
Treatment - Drugs
"Intervention group": Doxycycline(3 percent ) gel was manufactured by shahin khapour harmaceutical Laboratory,Tehran- Iran .
"Control group":Placebo gel of was prepared in the same manner but without the active drug in it (Made by the shahin khakpour of Pharmaceutical Laboratory,Tehran- Iran .

Sponsors

Deputy of Research Council of Dental Branch Islamic Azad University of Tehran
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to No maximum

Inclusion criteria

Inclusion criteria: "Inclusion criteria": patients with diabetes mellitus type II (at least 3 months before diagnosis, and A fasting blood sugar level of more than 125 mg/dl) and has periodontal disease is a chronic moderate (has a clinical attachment level of 3-4 mm) peritonitis, minimum of 16 natural teeth, and no periodontal treatment in the prior 6 months, had an glycated a hemoglobin (HbA1c) value between 7- 9 percent at screening, had reported no changes in diabetes medications within the last 3 months, were in the care of a physician for their diabetes. "Exclusion criteria": pregnancy or lactation, history of allergy to drugs used in the study; smoking; diabetes related emergency within 30 days ago; use of nonsteroidal anti-inflammatory drugs; or taking low dose daily aspirin (75-325 mg); use of immunosuppressive medications; antibiotic use; dialysis; risk of bleeding complications; the type of disease periodontal (Aggressive); a history of periodontal treatment in the previous 6 months; orthodontic treatment; using the removal prostheses; extensive dental caries; dental abscesses or infections.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Periodontal pocket. Timepoint: 15 days. Method of measurement: Periodontal probe.

Secondary

MeasureTime frame
Glycated hemoglobin (HbA1c). Timepoint: 3 months. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhossein Farahmand

Dental Branch Islamic Azad University of Tehran

perio-implant@hotmail.com+98 21 2284 9604

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026